Rare and Orphan Diseases - Global Cardiology Academy

1-16 of 57

Familial Chylomicronemia Syndrome: Improving Recognition and Diagnosis
Familial Chylomicronemia Syndrome: Improving Recognition and Diagnosis
On the Frontlines of Familial Chylomicronemia Syndrome
Familial Chylomicronemia Syndrome: Improving Recognition and Diagnosis
Steve Jackson, PharmD; Nivedita Patni, MD
- Steve Jackson, PharmD
- Nivedita Patni, MD
Closing Diagnostic Gaps in ATTR-CM
Closing Diagnostic Gaps in ATTR-CM
Heart Matters
Closing Diagnostic Gaps in ATTR-CM
Ronald Witteles, MD
- Ronald Witteles, MD
Early Recognition of ATTR-CM: Key Signs and Diagnostic Strategies
Early Recognition of ATTR-CM: Key Signs and Diagnostic Strategies
Heart Matters
Early Recognition of ATTR-CM: Key Signs and Diagnostic Strategies
Valmiki Maharaj, MD
- Valmiki Maharaj, MD
Recognizing and Managing Swelling in ATTR-CM
Recognizing and Managing Swelling in ATTR-CM
On the Frontlines of ATTR-CM
Recognizing and Managing Swelling in ATTR-CM
Steve Jackson, PharmD; Kevin S. Shah, MD
- Steve Jackson, PharmD
- Kevin S. Shah, MD
Early Detection of ATTR-CM: Clinical Clues and Imaging Approaches
Early Detection of ATTR-CM: Clinical Clues and Imaging Approaches
On the Frontlines of ATTR-CM
Early Detection of ATTR-CM: Clinical Clues and Imaging Approaches
Shelina Ramnarine, PhD; Valmiki Maharaj, MD
- Shelina Ramnarine, PhD
- Valmiki Maharaj, MD
Understanding Real-World Testing Patterns in ATTR-CM
Understanding Real-World Testing Patterns in ATTR-CM
On the Frontlines of ATTR-CM
Understanding Real-World Testing Patterns in ATTR-CM
Steve Jackson, PharmD; Ronald Witteles, MD
- Steve Jackson, PharmD
- Ronald Witteles, MD
Recognizing ATTR-CM in High-Risk Populations
Recognizing ATTR-CM in High-Risk Populations
On the Frontlines of ATTR-CM
Recognizing ATTR-CM in High-Risk Populations
Steve Jackson, PharmD; Frederick Ruberg, MD
- Steve Jackson, PharmD
- Frederick Ruberg, MD
The Limits of Traditional AFib Prediction Models in ATTR-CA
The Limits of Traditional AFib Prediction Models in ATTR-CA
Heart Matters
The Limits of Traditional AFib Prediction Models in ATTR-CA
Quality of Life Conversations in ATTR-CM Care
Quality of Life Conversations in ATTR-CM Care
Heart Matters
Quality of Life Conversations in ATTR-CM Care
Kevin S. Shah, MD
- Kevin S. Shah, MD
Counseling Patients on Disease Progression in ATTR-CM
Counseling Patients on Disease Progression in ATTR-CM
Heart Matters
Counseling Patients on Disease Progression in ATTR-CM
Joban Vaishnav, MD
- Joban Vaishnav, MD
Supporting Patients With ATTR-CM: Preserving Function and Quality of Life
Supporting Patients With ATTR-CM: Preserving Function and Quality of Life
Heart Matters
Supporting Patients With ATTR-CM: Preserving Function and Quality of Life
Joban Vaishnav, MD
- Joban Vaishnav, MD
Silencers and Stabilizers in ATTR-CM: Challenging Assumptions
Silencers and Stabilizers in ATTR-CM: Challenging Assumptions
Heart Matters
Silencers and Stabilizers in ATTR-CM: Challenging Assumptions
Rethinking Thromboembolic Risk in ATTR-CM Care
Rethinking Thromboembolic Risk in ATTR-CM Care
Heart Matters
Rethinking Thromboembolic Risk in ATTR-CM Care
Rebalancing Amyloid in ATTR-CM: Emerging Therapeutic Insights
Rebalancing Amyloid in ATTR-CM: Emerging Therapeutic Insights
AudioAbstracts
Rebalancing Amyloid in ATTR-CM: Emerging Therapeutic Insights
Hallie Blevins, PhD
- Hallie Blevins, PhD
Heart Failure Hospitalization and Mortality in Cardiac Amyloidosis
Heart Failure Hospitalization and Mortality in Cardiac Amyloidosis
Heart Matters
Heart Failure Hospitalization and Mortality in Cardiac Amyloidosis
Disease-Modifying Advances in ATTR-CM Management
Disease-Modifying Advances in ATTR-CM Management
Heart Matters
Disease-Modifying Advances in ATTR-CM Management

Prev
1
2
3
4
Next

1/4